Paper · 28928126
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 92
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22160384 | B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. | Blood | 2012 | https://conductscience.org/library/papers/22160384 | PubMed |
| 2 | 28291388 | Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28291388 | PubMed |
| 3 | 27207799 | Toxicities of chimeric antigen receptor T cells: recognition and management. | Blood | 2016 | https://conductscience.org/library/papers/27207799 | PubMed |
| 4 | 26726943 | Allogeneic stem cell transplantation for multiple myeloma: is there a future? | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/26726943 | PubMed |
| 5 | 29061640 | Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29061640 | PubMed |
| 6 | 7913116 | Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. | J Immunol | 1994 | https://conductscience.org/library/papers/7913116 | PubMed |
| 7 | 19047103 | Preclinical characterization of SGN-70, a humanized antibody directed against CD70. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/19047103 | PubMed |
| 8 | 25995224 | Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25995224 | PubMed |
| 9 | 6460831 | Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. | J Exp Med | 1982 | https://conductscience.org/library/papers/6460831 | PubMed |
| 10 | 22766978 | Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. | Int J Oncol | 2012 | https://conductscience.org/library/papers/22766978 | PubMed |
| 11 | 24311149 | Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies. | Int J Hematol | 2014 | https://conductscience.org/library/papers/24311149 | PubMed |
| 12 | 27270177 | Clinical responses with T lymphocytes targeting malignancy-associated κ light chains. | J Clin Invest | 2016 | https://conductscience.org/library/papers/27270177 | PubMed |
| 13 | 19561539 | Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. | J Immunother | 2009 | https://conductscience.org/library/papers/19561539 | PubMed |
| 14 | 24876563 | Current concepts in the diagnosis and management of cytokine release syndrome. | Blood | 2014 | https://conductscience.org/library/papers/24876563 | PubMed |
| 15 | 16203864 | Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. | J Exp Med | 2005 | https://conductscience.org/library/papers/16203864 | PubMed |
| 16 | 24055823 | Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. | Blood | 2013 | https://conductscience.org/library/papers/24055823 | PubMed |
| 17 | 10931011 | Controversies surrounding the clonogenic origin of multiple myeloma. | Br J Haematol | 2000 | https://conductscience.org/library/papers/10931011 | PubMed |
| 18 | 24553386 | Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24553386 | PubMed |
| 19 | 21830940 | Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21830940 | PubMed |
| 20 | 27998219 | How to Integrate Elotuzumab and Daratumumab Into Therapy for Multiple Myeloma. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27998219 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/28928126/references